Balaji Amines Ltd

Balaji Amines Ltd Share Price Today: Live Updates & Key Insights

Get insights on Balaji Amines Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Balaji Amines Ltd Share Price Chart

Balaji Amines Ltd Fundamentals

Traded Volume: 51,831

Market Cap(Cr): 3,820

Avg Traded Price 1180.54

1 Year return -40.58%

Upper Circuit 1,194.9

Lower Circuit 1,171

P/E TTM 26.00

P/B Ratio 45.00

Traded Value(Cr) 611.14

EPS TTM 45.001

Book value 45.001

Dividend 1.00%

Balaji Amines Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Balaji Amines Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Balaji Amines Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -6.24%

1M -15.11%

3M -24.48%

1Y -40.58%

YTD -33.70%

Balaji Amines Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Balaji Amines Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 82781.00

Day Before Yesterday 80534.00

1W Avg 72525.60

1M Avg 47395.24

3M Avg 36252.26

Balaji Amines Ltd Technical Details

Balaji Amines Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 1168

Support 2 1158

Support 3 1145

Pivot Point : 1182

Resistance 1 1192

Resistance 2 1206

Resistance 3 1216

Balaji Amines Ltd Corporate Actions

Balaji Amines Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Balaji Amines Ltd’s capital allocation strategies.

All

Ex-Date 01-Aug-2025 Type D Description 11.00/share@550.00% Record Date 01-Aug-2025 Ratio 550.00

Ex-Date 04-Jul-2024 Type D Description 11.00/share@550.00% Record Date - Ratio 550.00

Ex-Date 03-Jul-2023 Type D Description 10.00/share@500.00% Record Date - Ratio 500.00

Ex-Date 21-Jun-2022 Type D Description 6.00/share@300.00% Record Date - Ratio 300.00

Ex-Date 29-Jul-2021 Type D Description 4.00/share@200.00% Record Date - Ratio 200.00

Ex-Date 30-Jul-2020 Type D Description 0.60/share@30.00% Record Date - Ratio 30.00

Ex-Date 17-Mar-2020 Type D Description 2.60/share@130.00% Record Date 18-Mar-2020 Ratio 130.00

Ex-Date 17-Jul-2019 Type D Description 2.80/share@140.00% Record Date - Ratio 140.00

Ex-Date 20-Aug-2018 Type D Description 2.60/share@130.00% Record Date - Ratio 130.00

Ex-Date 20-Jul-2017 Type D Description 2.20/share@110.00% Record Date - Ratio 110.00

Ex-Date 21-Jul-2016 Type D Description 2.00/share@100.00% Record Date - Ratio 100.00

Ex-Date 15-Sep-2015 Type D Description 1.20/share@60.00% Record Date - Ratio 60.00

Ex-Date 22-Sep-2014 Type D Description 1.00/share@50.00% Record Date - Ratio 50.00

Ex-Date 23-Sep-2013 Type D Description 0.50/share@25.00% Record Date - Ratio 25.00

Ex-Date 23-Sep-2013 Type D Description 0.80/share@40.00% Record Date - Ratio 40.00

Ex-Date 19-Jul-2012 Type D Description 0.80/share@40.00% Record Date - Ratio 40.00

Ex-Date 14-Jul-2011 Type D Description 0.60/share@30.00% Record Date - Ratio 30.00

Ex-Date 18-Nov-2010 Type S Description share@1:5.00 Record Date 19-Nov-2010 Ratio 1:5.00

Ex-Date 30-Aug-2010 Type D Description 2.50/share@25.00% Record Date - Ratio 25.00

Ex-Date 17-Aug-2009 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00

Ex-Date 12-Sep-2008 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00

Ex-Date 30-Aug-2007 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00

Ex-Date 05-Mar-2007 Type B Description share@1:1 Record Date 06-Mar-2007 Ratio 1:1

Dividends

Announcement Date 01-Aug-2025 Ex Dividend Date 01-Aug-2025 Dividend(%) 550

Announcement Date 04-Jul-2024 Ex Dividend Date 04-Jul-2024 Dividend(%) 550

Announcement Date 03-Jul-2023 Ex Dividend Date 03-Jul-2023 Dividend(%) 500

Announcement Date 21-Jun-2022 Ex Dividend Date 21-Jun-2022 Dividend(%) 300

Announcement Date 29-Jul-2021 Ex Dividend Date 29-Jul-2021 Dividend(%) 200

Announcement Date 30-Jul-2020 Ex Dividend Date 30-Jul-2020 Dividend(%) 30

Announcement Date 17-Mar-2020 Ex Dividend Date 17-Mar-2020 Dividend(%) 130

Announcement Date 17-Jul-2019 Ex Dividend Date 17-Jul-2019 Dividend(%) 140

Announcement Date 20-Aug-2018 Ex Dividend Date 20-Aug-2018 Dividend(%) 130

Announcement Date 20-Jul-2017 Ex Dividend Date 20-Jul-2017 Dividend(%) 110

Announcement Date 21-Jul-2016 Ex Dividend Date 21-Jul-2016 Dividend(%) 100

Announcement Date 15-Sep-2015 Ex Dividend Date 15-Sep-2015 Dividend(%) 60

Announcement Date 22-Sep-2014 Ex Dividend Date 22-Sep-2014 Dividend(%) 50

Announcement Date 23-Sep-2013 Ex Dividend Date 23-Sep-2013 Dividend(%) 25

Announcement Date 23-Sep-2013 Ex Dividend Date 23-Sep-2013 Dividend(%) 40

Announcement Date 19-Jul-2012 Ex Dividend Date 19-Jul-2012 Dividend(%) 40

Announcement Date 14-Jul-2011 Ex Dividend Date 14-Jul-2011 Dividend(%) 30

Announcement Date 30-Aug-2010 Ex Dividend Date 30-Aug-2010 Dividend(%) 25

Announcement Date 17-Aug-2009 Ex Dividend Date 17-Aug-2009 Dividend(%) 20

Announcement Date 12-Sep-2008 Ex Dividend Date 12-Sep-2008 Dividend(%) 15

Announcement Date 30-Aug-2007 Ex Dividend Date 30-Aug-2007 Dividend(%) 15

Bonus

Record Date 06-Mar-2007 Ex-Bonus Date 05-Mar-2007 Ratio 1:1

Splits

Record Date 19-Nov-2010 Split Date 18-Nov-2010 Face Value (Before/After) 10.00/2.00

Others

Rights No Rights has been declared by BALAMINES

Balaji Amines Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Balaji Amines Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Balaji Amines Ltd's relative performance and valuation against major competitors.

Stock Name Epigral Ltd ₹1451.80 (-0.24%) M. Cap (Cr) 62.63 1 Yr Return (%) -24.74% P/E (TTM) 15.56 PB Ratio 3.29

Stock Name Laxmi Organic Industries Ltd ₹182.74 (-0.34%) M. Cap (Cr) 50.65 1 Yr Return (%) -25.69% P/E (TTM) 60.67 PB Ratio 2.66

Stock Name Chemplast Sanmar Ltd ₹308.45 (-2.54%) M. Cap (Cr) 48.77 1 Yr Return (%) -36.76% P/E (TTM) -22.34 PB Ratio 44.04

Stock Name Balaji Amines Ltd ₹1179.10 (-1.37%) M. Cap (Cr) 38.20 1 Yr Return (%) -40.58% P/E (TTM) 26.20 PB Ratio 2.16

Stock Name Styrenix Performance Materials Ltd ₹2039.40 (-1.34%) M. Cap (Cr) 35.87 1 Yr Return (%) -15.57% P/E (TTM) 17.89 PB Ratio 3.07

Stock Name Rossari Biotech Ltd ₹614.35 (-0.77%) M. Cap (Cr) 34.02 1 Yr Return (%) -19.80% P/E (TTM) 24.90 PB Ratio 2.87

Stock Name Tatva Chintan Pharma Chem Ltd ₹1449.10 (-5.42%) M. Cap (Cr) 33.90 1 Yr Return (%) +79.38% P/E (TTM) 191.12 PB Ratio 4.60

Balaji Amines Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Balaji Amines Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 224.35 Mar 2024 170.05 Mar 2023 215.50 Mar 2022 167.87 Mar 2021 93.92

PARTICULARS Investing Activities Mar 2025 -179.24 Mar 2024 -143.84 Mar 2023 -132.37 Mar 2022 -117.85 Mar 2021 -86.55

PARTICULARS Financing Activities Mar 2025 -37.52 Mar 2024 -34.58 Mar 2023 -22.17 Mar 2022 -19.55 Mar 2021 3.02

PARTICULARS Net Cash Flow Mar 2025 7.59 Mar 2024 -8.36 Mar 2023 60.95 Mar 2022 30.47 Mar 2021 10.39

Balaji Amines Ltd Shareholding Pattern

This shows the ownership breakdown of Balaji Amines Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 54.59%

Public 39.37%

Other Institutions 1.4%

FII 4.53%

Mutual Funds 0.12%

About Balaji Amines Ltd

Promoted by the KPR Group of Industries, Balaji Amines Limited (BAL) was incorporated on October 27, 1988. The Company is a leading Indian manufacturer of ethyl and methyl amines which have various applications in chemical industries. It is presently engaged in manufacture and sale of Speciality Chemicals, Pharma Excipients, Aliphatic Amines and Derivatives. Apart from this, it has now diversified into producing derivatives of methyl and ethyl amines, namely, Di-Methyl Amine Hydrochloride (DMA-HCl), Choline Chloride, Di Methyl Acetamide, etc. At present, the Company supply to various Blue Chip Companies like IDI, Hoechst, Rallis, Ion Exchange, Cheminor Drugs, TTK Pharma, etc. It has 4 manufacturing facilities, three plants at Tuljapur and Chincholi in Maharashtra and one at Medak, Telangana. It owns a Five Star Hotel in Solapur, Maharashtra and has CFL lamps facility at Medak, Telangana. The Company presently operates in three segments i.e., Specialty Chemicals and Amines, Hotel and CFL Lamps. A new facility for manufacture of Speciality Chemicals is under construction at Chicholi, Maharashtra.On May '95, it came out with a public issue of 9.63 lac equity shares (premium : Rs 30), aggregating Rs 3.85 cr to part-finance expansion plans for ethylamines and forward integration for the manufacture of derivatives of methyl and ethyl amines, totaling to Rs 10 cr. In 1988, the Company started business operations.In 1989, it started to produce Methyl Amines and Ethyl Amines.In 1992, the Company established R&D Centre at Hyderabad.In 1995, it started manufacturing drug intermediate -Dimethyl Amine Hydrochloride.In 1997-98, the company has successfully commenced the commercial operation of its main plant (Ethyl Amines) from June, 1997.In 2000, it added derivatives of Methyl and Ethyle Amines to the product portfolio.In 2001, the Company was certified with ISO:9001.Expansion programme has been taken up for value-added products like Choline Chloride, DMAE-HCI and other intermediates at a cost of Rs.500 lacs. The project has been appraised by State Bank of Hyderabad and Bank of India for a term loan of Rs.290 lacs and Rs.100 lacs respectively.The balance would be met out by the internal accruals of the company.The project would be implemented on phases and the first phase is likely to be commissioned during the current year 2001-2002.During the year 2003, Company was awarded Recognized Export House status from Government of India, Ministry of Commerce, New Delhi. It increased the capacity of Methyl Amines.In 2005, the Company developed more specialty chemicals.In 2006, it founded Balaji Foundation and Research Centre for the rural population as a part of CSR activity. It became the sole manufacturerof GBI, NMP, and Morpholine.During the year 2009, the Company started power generation through windmill by establishing 1.5 MW windmill unit at Satara, Maharashtra. It established an R & D GBL Plant at Tamalwadi, Solapur. It commenced setting up 2.5 MW Co-Generation Power Plant Unit at Tamalwadi and PVP Plant at Chincholi, in Solapur respectively. Apart from this, it secured the `Certificate of Merit' for Outstanding Export by Chemexcil.During the year 2010, 2.5 Mw Co- Generation Power Plant at Tamalwadi, Solapur has been commissioned in July, 2009. Besides this, the PVP Plant at Chincholi, Solapur has started producing various grades and the mandatory approvals are in final stages.In 2010, the Company installed wind turbine for generating in-house electricity to start focusing on renewable energy.In 2012, the Company received Certificate of Suitability certification from European Directorate for the Quality Medicines & Health Care (EDQM), Europe for its product PVPK-30. It also received WHOGMP certification and REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) for four products namely, Triethylamine, Gammabutyrolactone, N-Ethylamine-2-Pyrrolidone along with the already registered N-methyl 2 Pyrrolidone (NMP). It has been awarded for the category of Best Manufacturer - Exporter (Medium) at the `Indian Exporter Excellence Awards 2012 instituted by the Export Credit Guarantee Corporation of India Limited (ECGC)[An Indian Govt. Undertaking], in association with Dun and Bradstreet (D&B), which seeks to recognize leading exporters for their excellence in their respective fields. In October 2013, the Company inaugurated its 129 Room Five-Star Hotel Property `Balaji Sarovar Premiere' with an investment of Rs. 110 crore. It executed the commissioning of DMF manufacturing Plant. Further, two new plants, one for the first phase of Di-Methyl Amine Hydrochloride (DMA-HCL) with an installed capacity of 7500 MT per annum commissioned in the month of February, 2013 and second plant for manufacture of Di Methyl Formamide (DMF) with an installed capacity of 30000 MT / P. A at MIDC Chincholi, Solapur has been commissioned in the month of March, 2013. During the year 2013, Company's 5 star Hotel Property started commercially from 1st November 2013 which is being managed by Sarovar Group of Hotels.In 2014, the Company was awarded for Balaji Sarovar Premium's `eco-friendly Green technology'.During the year 2015, Company successfully re-commissioned its DMF plant by strengthening the Carbon Monoxide plan. In 2015, it was awarded another `Certificate of Excellence' for Balaji Sarovar Premiere from the `Trip Advisor `on the basis of customer reviews for excellent food, service and hospitality.In 2016, it set up a plant to manufacture Acetonitrile.During the year 2017-18, the subsidiaries of the Company viz. Bhagyanagar Chemicals Limited (company's holding 100%) and Balaji Greentech Products Limited (company's holding 66%) were amalgamated with BAL (the Company) as per the scheme of amalgamation sanctioned by the Hon'ble NCLT, Mumbai.In 2018, the Company was 90 acres of land at MIDC, Chincholi with Mega Project Status for this new project by Maharashtra State Government. It commissioned a new plant for manufacture of Morpholine and Acetonitrile after successful trial runs.In 2019, the Company set up a new plant project under its subsidiary, Balaji Specialty Chemicals Private Limited, which got completed in a record 12 months. In 2021, Company commenced operation in Greenfield Project at Unit-IV. The Boiler of 50 TPH capacity was commissioned during FY 2021-22, with a capex of Rs 19.76 Crores. The Company commissioned a New Ethylamines Plant Phase I of its Greenfield Project. During FY 23, the Company commissioned Phase I (Unit IV) DMC, PG and PC plants, comprising the production capacity of 15,000 tons of Di-methyl Carbonate (DMC)/ Propylene Carbonate (PC) and 15,000 tons of Propylene Glycol (PG).Methylamines Plant at Unit IV was commissioned on 10 November 2024, which expanded the production capacity to 88,000 MT in FY 2025. First phase of Solar power plant of 8 MW DC (6 MW AC) commissioned on 2nd April 2025. Electronic Grade Di Methyl Carbonate (DMC) Plant got commissioned on May 28, 2025.

Executive Chairman

A Prathap Reddy

Registered office Balaji Towers No 9/1A/1, Hotgi Road Aasara Chowk, Solapur, Maharashtra, 413224

FAX :91-217-2310824

Background

Incorporation Year 1988

Face Value ₹2.00

Market Lot 1

Balaji Amines Ltd Latest News

VIEW MORE NEWS

FAQs on Balaji Amines Ltd